Uterine mast cells: A new hypothesis to understand how we are born

Biocell

Volumn 28, Issue 1, 2004, Pages 1-11

  Rudolph, M Isolde ^a   Rojas, I Gina ^a   Penissi, Alicia B ^b  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Cervical ripening; Labor; Myometrium contractions; Uterine mast cells

Indexed keywords

BIRTH; DELIVERY; ENDOCRINE SYSTEM; FEMALE GENITAL SYSTEM; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; LABOR; MAMMAL; MAST CELL; NERVOUS SYSTEM; NONHUMAN; PREGNANCY; REVIEW; SPECIES; UTERUS;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; FEMALE; GONADAL STEROID HORMONES; HUMANS; MAST CELLS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; OXYTOCIN; PARTURITION; PREGNANCY; UTERUS;

MAMMALIA;

EID: 2442641506     PISSN: 03279545     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (114)

1. Aggelidou E, Hillhouse EW, Grammatopoulus DK (2002). Up-regulation of nitric oxide synthase and modulation of guanylate cyclase activity by corticotropin-relesing hormone but not urocortin II or urocortin II in cultured human pregnant myometrial cells. Proc Natl Acad Sci USA. 99: 3300-3305.
2. Armetti L, Admon D, Solomon A, Levi-Schaffer F (1999). mast cells and eosinophils. Their role in tissue remodeling. ACI International. 11: 22-28.
3. Asselin E, Drolet P, Fortier MA (1997). Cellular mechanism involved during oxytocin-induced prostaglandin F2a production in endometrial epithelial cells in vitro: Role of cyclooxygenase-2. Endocrinology. 138: 4798-4805.
4. Bokstrom H, Brannstrom M, Alexandersson M, Norstrom A (1997). Leukocyte subpopulations in human uterine cervical stroma at early and term pregnancy. Hum Reprod. 12: 586-590.
5. Brightling C, Symon F, Holgate S, Wardlaw A, Pavord I, Bradding P (2003). Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma. Clin Exp Allergy. 33: 1711-1716.
6. Bytautiene E, Vedernikov YP, Saade GR, Romero R, Garfield RE (2003). Effect of histamine on phasic and tonic contractions of isolated uterine tissue from pregnant women. Am J Obstet Gynecol. 188: 774-778.
7. Cabanillas-Saez A, Schalper JA, Nicovani SM, Rudolph MI (2002). Characterization of mast cells according to their content of tryptase and chymase in normal and neoplastic human uterine cervix. Int J Gynecol Cancer. 12: 92-98.
8. Cantarella G, Iempercur L, Lombardo G, Chiarenza A, Pafumi C, Zappala G, Bernardini R (2001). Divergent effects of corticotropin releasing hormone on endothelial cell nitric oxide synthase are associated with different expression of CRH type 1 and 2 receptors. Br J Pharmacol. 134: 837-844.
9. Challis JRG, Lye SJ (1994). Parturition. In: The Physiology of Reproduction. E Knobil, JD Neil, Eds. Raven Press, New York: Vol 2.
10. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL (1996). Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 335: 1010-1015.
11. Chrousos GP, Torpy D, Gold PW (1998). Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive systems. Ann Intern Med. 129: 229-240.
12. Chung YP, Hwa HL, Ko TM (1999). Laminaria and sulprostone in second trimester pregnancy termination for fetal abnormalities. Int J Gynecol Obstetr. 65: 47-52.
13. Church MK, Levy-Schaffer F (1997). The human mast cell. J Allergy Clin Immunol. 99: 155-160.
14. Chwalisz K, Garfield RE (1998). Role of nitric oxide in the uterus and cervix: implications for the management of labor. J Perinat Med. 26: 448-457.
15. Clifton VL, Read MA, Leitch IM, Giles WB, Boura AL, Robinson PJ, Smith R (1995). Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of nitric oxide-cyclic guanosine 3′,5′-monophosphate pathways. J Clin Endocrinol Metab. 80: 2888-2893.
16. Cocchiara R, Bongiovanni A, Albeggiani G, Azzolina A, Geraci D (1997a). Sustance P selectively activates TNFa mRNA in rat uterine ummune cells: a neuroimmune link. Neuroreport. 8: 2961-2964.
17. Cocchiara R, Bongiovanni A, Albeggiani G, Azzolina A, Lampiasi N, Di Blasi F, Geraci D (1997b). Inhibitory effect of neuraminidase on SP-induced histamine release and TNF-alpha mRNA in rat mast cells: evidence of a receptor-independent mechanism. J Neuroimmunol. 75: 9-18.
18. Cocchiara R, Albeggianni G, Di Trapani G, Azzolina A, Lampiasi N, Rizzo F, Diotallevi L, Gianaroli L, Geraci D (1992). Oestradiol enhances in vitro the histamine release induced by embrionic histamine-releasing factor (EHGF) from uterine mast cells. Human Reprod. 7: 1036-1041.
19. Coleman J (2002). Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation. Clin Exp Immunol. 129: 4-10.
20. Costa JJ, Burd PR, Metcalfe DD (1994). Mast cell cytokines. In: The mast cell in health and disease, MA Kaliner and DD Metcalfe, Eds., Marcel Dekker, New York, pp. 443-466.
21. Cruz MA, González C, Acevedo CG, Sepúlveda WH, Rudolph MI (1989). Effects of histamine and serotonin on the contractility of isolated pregnant and nonpregnant human myometrium. Gynecol Obstet Invest. 28: 1-4.
22. Edgerton LA, Kaminski MA, Silvia MJ (1996). Changes in uterine secretion of prostaglandin F2alpha in response to oxytocin during estrous cycle, early pregnancy and estrogen-induced pseudopregnancy in swine. Biol Reprod. 55: 657-662.
23. Evans CH, Stefanovic-Racic M, Lancaster J (1995). Nitric oxide and its role in orthopaedic disease. J Clin Orthop Rel Res. 312: 275-294.
24. Fajardo I, Pejler G (2003). Human mast cell beta-tryptase is a gelatinase. Journal of immunology (Baltimore, Md: 1950). 171: 1493-1499.
25. Fidel PL, Romero R, Cutright J, Wolf N, Gomez R, Araneda H, Ramirez M, Yoon BH (1997). Treatment with the interleukin-1 receptor antagonist and soluble tumor necrosis factor receptor Fc fusion protein does not prevent endotoxin-induced preterm parturition in mice. J Soc Gynecol Invest. 4: 22-26.
26. Franchi A, Chaud M, Rettori V, Suburo A, McCann S, Gimeno M (1994). Role of nitric oxide in eicosanoid synthesis and uterine motility in estrogen-treated rat uteri. Proc Natl Acad Sci USA. 91: 539-543.
27. Galli SJ, Wershil BK, Mekori YA (1987). Analysis of mast cell function in biological responses not involving IgE. Int Arch Allergy Appl Immunol. 82: 269-271.
28. Galli SJ, Zsebo KM, Geissler EN (1994). The kit ligand, stem cell factor. Adv Immunol. 55: 1-96.
29. Galli SJ, Maurer M, Lantz CS (1999). Mast cells as sentinels of innate immunity. Curr Opin Immunol. 11: 53-59.
30. Garfield RE (1994). Role of cell-to-cell coupling in control of myometrial contractility and labor: In: Control of uterine contractility RE Garfield and TN Tabb, Eds, CRC Press Inc., Boca Raton, FLA. pp. 39-81.
31. Goldstain DJ (1995). Effects of third trimester fluoxetine exposure on the newborn. J Clin Psychopharmacol. 15: 417-420.
32. Goldstain DJ, Sundell KL, Corbin LA (1997). Birth outcomes in pregnant women taking fluoxetine (letter). N Engl J Med. 336: 872-873.
33. Gordon JR, Galli SJ (1990). Mast cells as a source of both preformed and immunologically inducible TNK/cachectin. Nature. 19: 274-276.
34. Harris S, Phipps R (2002). Prostaglandin D(2), its metabolite 15-d-PGJ(2), and peroxisome proliferator activated receptor-gamma agonists induce apoptosis in transformed, but not normal, human T lineage cells. Immunology. 105: 23-.
35. Hatthachote P, Gillespie JI (1999). Complex interactions between sex steroids and cytokines in the human pregnant myometrium: Evidence for an autocrine signaling system at term. Endocrinology. 140: 2533-2540.
36. Hattori Y, Nerusu KC, Bhagavathula N, Brennan M, Hattori N, Murphy HS, Su LD, Wang TS, Johnson TM, Varani J (2003). Vascular expression of matrix metalloproteinase-13 (collagenase-3) in basal cell carcinoma. Exp Mol Pathol. 74: 230-237.
37. Hollingsworth M, Edwards D, Miller M (1988). Ergometrine a partial agonist at 5HT receptors in the uterus isolated from estrogen-primed rat. Eur J Pharmacol. 158: 79-84.
38. Huang J, Roby K, Pace J, Russell S, Hunt J (1995). Cellular localization and hormonal regulation of inducible nitric oxide synthase in cycling mouse uterus. J Leukoc Biol. 57: 27-35.
39. Hunt JS, Miller L, Roby KF, Huang J, Platt JS, DeBrot BL (1997). Female steroid hormones regulate production of pro-inflammatory molecules in uterine leukocytes. J Reprod Immunol. 35: 87-99.
40. Imamura T, Luedke CE, Vogt SK, Muglia LJ (2000). Oxytocin modulates the onset of murine parturition by competing ovarian and uterine effects. Am J Physiol. 279: R1051-R1057.
41. Jeziorska M, Salamonsen LA, Woolley DE (1995). Mast cell and eosinophil distribution and activation in human endometrium throughout the menstrual cycle. Biol Reprod. 53: 312-320.
42. Jones SA, Challis JRG (1989). Local stimulation of prostaglandin production by corticotrophin-releasing hormone in human female membranes and placenta. Biochem Biophys Res Commun. 159: 192-199.
43. Katzenellenbogen BS (1996). Estrogen receptors: Bioactivities and interactions with cell signalling pathways. Biol Reprod. 54: 287-293.
44. Kempuraj D, Papadopoulou N, Lytinas M, Huang M, Kandere-Grzybowska K, Madhappan B, Boucher W, Christodoulou S, Athanassiou A, Theoharides T (2003). Corticotropin-Releasing Hormone (CRH) and its Structurally Related Urocortin (Ucn) are Synthesized and Secreted by Human Mast Cells. Endocrinology.(e-pub)
45. Klein VR, Harris AP, Abraham RA, Niebyl JR (1984) Fetal distress during maternal systemic allergic reaction. Obstet Gynecol. 64: 155-175.
46. Konopka T, Barker J, Bamford T, Guida E, Anderson R, Stewart A (2001). Nitric oxide synthase II gene disruption: implications for tumor growth and vascular endothelial growth factor production. Cancer Research. 61: 3182-.
47. Krishnaswamy G, Kelley J, Johnson D, Younberg G, Stone W, Huang S-K, Bieber J, Chi DS (2001). The human mast cell: functions in physiology and disease. Front Biosci. 6: 1109-1127.
48. Krishnaswamy G, Lakshman T, Miller AR, Srikanth S, Hall K, Huang SK, Suttles J, Smith JK, Stout R (1997). Multifunctional cytokine expression by human mast cells: regulation by T cell membrane contact and corticoids. J Interferon Cytokine Res. 17: 167-176.
49. Leake RD, Weitzman RE, Glatz TH, Fisher DH (1981). Plasma oxytocin concentration in men, non-pregnant women, and pregnant women before and during spontaneous labor. J Clin Endocrinol Metab. 53: 730-733.
50. Lees C, Campbell S, Jauniaux E, Brown R, Ramsay B, Gibb D, Moncada S, Martin JF (1994). Arrest of preterm labour and prolongation of gestation with glyceryl trinitrate, a nitric oxide donor. Lancet. 343: 1325-1326.
51. Lefebvre DL, Giaid A, Zingg HH (1992a). Expression of the oxytocin gene in rat placenta. Endocrinology. 130: 1185-.
52. Lefebvre DL, Giaid A, Bennett H, Lariviere R, Zingg HH (1992b). Oxytocin gene expression in rat uterus. Science. 256: 1553-.
53. Lemura A, Tsai M, Ando A, Wershil BK, Galli SJ (1994). The c-kit ligand, stem cell factor, prometes mast cell survival by suppressig apoptosis. Am J Pathol. 144: 321-328.
54. Leon A, Buriani A, Dal Toso R, Fabris M, Romanello S, Aloe L, Levi-Montalcini R (1994). Mast cells synthezise, store, and release nerve growth factor. Proc Natl Acad Sci USA. 91: 3739-3743.
55. Lepert PC (1995). Anatomy and physiology of cervical ripening. Clin Obstet Gynecol. 38: 267-279.
56. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW (2001). Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A. 98: 7570-7575.
57. Lye SJ (1996). Initiation of parturition. Anim Reprod Sci. 42: 495-503.
58. Madhappan B, Kempuraj D, Christodoulou S, Tsapidikidis S, Boucher W, Theorarides TC (2003). High levels of intrauterine corticotropin-releasing hormone, urocotrin, tryptase, and interleukin-8 in spontaneous abortions. Endocrinology. 144: 2285-2290.
59. Magocsi M, Penniston JC (1991). Oxytocin pretreatment of pregnant rat uterus inhibits Ca uptake in plasma membrane and sarcoplasmic reticulum. Biochem Biophys Acta. 1063: 7-12.
60. Majzoub JA, Mcgregor JA, Lockwood CJ, Smith R, Snyder-Tagart M, Schulkin J (1999). A central theory of preterm and term labor: Putetive role for corticotropin-releasing hormone. Am J Obstet Gynecol. 180: S232-S241.
61. Martinez L, Gimeno MF, Villán L, Villar M, Rudolph MI (1999). Nitroprusside stimulates contractility and the synthesis of 14C-acetylated PAF-like substances in estrogen primed-mouse uterine horns. Prostaglandins Other Lipid Mediat. 57: 49-62.
62. Masini E, Bani D, Bigazzi M, Mannaioni PF, Bani-Sacchi T (1994). Effects of relaxin on mast cells. In vitro and in vivo studies in rats and guinea pigs. J Clin Invest. 94: 1974-1980.
63. Massey WA, Guo C-B, Dvorak AM, Hubbard WC, Bhagavan BS, Cohan VL, Warner JA, Kagey-Sobotka A, Lichtenstein LM (1991). Human uterine mast cells. Isolation, purification, characterization, ultraestructure, and pharmacology. J Immunol. 147: 1621-1627.
64. McCoshen JA, Hoffman DR, Kredentser JV, Araneda C, Johnston JM (1990). The role of fetal membranes in regulating prosuction, transport, and metabolism of prostaglandin E2 during labor. Am J Obstet Gynecol. 163: 1632-1640.
65. McNeil HP, Austen KF (1995). Biology of the mast cell. In: Samter's Immunologic Diseases. Eds. MM Frank, KF Austes, HN Claman, ER Unanue Eds. Little. Brown and Co., NY. pp. 185-204.
66. Metcalfe D, Baram D, Mekori Y (1997). Mast cells. Physiol Reviews. 77: 1033-1079.
67. Metcalfe DD, Akin C (2001). Mastocytosis: molecular mechanisms and clinical disease heterogeneity. Leuk Res. 25: 577-582.
68. Mitchell BF, Smid B (2001). Oxytocin and its receptor in the process of parturition. J Soc Gynecol Invest. 8: 122-133.
69. Mori A, Nakayama K, Suzuki J, Nikaido T, Isobe M, Fujii S (1997). Analysis of stem cell factor for mast cell proliferation in the human myometrium. Mol Hum Reprod. 3: 411-418.
70. Motta AB, Gonzalez ET, Rudolph MI, Gimeno MF (1999). Regulation of prostaglandin production by nitric oxide in rat smooth muscle myometrial cells. Prostaglandins Leukot Essent Fatty Acids. 60: 73-76.
71. Ni X, Nicholson RC, King BR, Chan E-C, Read MA, Smith R (2002). Estrogen represses whereas the estrogen-antagonist ICI 182780 stimulates placental CRH gene expression. J Clin Endocrinol Metab. 87: 3774-3778.
72. Nilsson G, Schwartz LB (1995). Mast cell heterogeneity: Structure and mediators. In: Asthma and Rinitis. WW Busse, ST Holgate, Eds., Blackwell Sci, Boston. pp. 195-208.
73. Okayama Y, Kobayashi H, Ashman L, Holgate S, Church M, Mori M (1997). Activation of eosinophils with cytokines produced by lung mast cells. Int Arch Allergy & Immunol. 114 Suppl 1: 75-77.
74. Olund A, Kindahl H, Oliw E, Lindgren A, Larsson B (1980). Prostaglandins and thromboxanes in amniotic fluid during rivanol-induced abortion and labor. Prostaglandins. 19: 701-800.
75. Ou C-W, Chen Z-Q, Qi S, Lye SJ (1998). Increased expression of the rat myometrial oxytocin receptor messenger ribonucleic acid during labor requires both mechanical and hormonal signals. Biol Reprod. 59: 1055-1061.
76. Padilla L, Reinicke K, Montesino H, Villena F, Asencio H, Cruz MA, Rudolph MI (1990). Histamine content and mast cell distribution in mouse uterus: The effect of sexual hormones, gestation and labor. Cell Mol Biol. 36: 93-100.
77. Pang X, Cotreau-Bibbo MM, Sant GR, Theoharides TC (1995). Bladder mast cell expression of high affinity oestrogen receptors in patients with interstitial cystitis. Br J Urol. 75: 151-161.
78. Pasqualini JR, Kincl F (1985). Hormones and the fetus. Pergamon Press, Oxford.
79. Passaretti TV, Wilcox BD, Jeffrey JJ (1996). Serotonin regulation of gene expression in uterine extracellular matrix: reciprocal effects on collagens and collagenase. Mol Cell Endocrinol. 120: 125-132.
80. Penissi A, Rudolph M, Piezzi R (2003a). Role of mast cells in gastrointestinal mucosal defense. Biocell. 27: 163-172.
81. Penissi A, Rudolph I, Fogal T, Piezzi R (2003b). Changes in duodenal mast cells in response to dehydroleucodine. Cells Tissues Organs. 173: 234-241.
82. Petraglia F, Fluorio P, Gallo R (1996). Human placenta and fetal membranes express human urocortin mRNA and peptide. J Clin Endocrino Metab. 81: 3807-3810.
83. Puxeddu I, Piliponsky A, Bachelet I, Levi-Schaffer F (2003). Mast cells in allergy and beyond. International Journal of Biochemistry & Cell Biology. 35: 1601-1605
84. Robinson BG, Arbiser JL, Emanuel RL, Majzoub JA (1989). Species-specific placental corticotropin-releasing hormone messenger RNA and peptide expression. Mol Cell Endocrinol. 61: 337-341.
85. Roby KF, Hunt JS (1995). Myometrial tumor necrosis factor alpha: cellular localization and regulation by estradiol and progesterone in the mouse. Biol Reprod. 52: 509-515.
86. Romero R, Sirtori M, Oyarzun E, Avila C, Mazor M, Callahan R, Sabo V, Athanassiadis AP, Hobbins JC (1989). Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol. 161: 817-824.
87. Roseblade CK, Sullivan MHF, Khan H, Lumb MR, Elder MG (1990). Limited transfer of prostaglandin E2 across the fetal membranes before and after labor. Acta Obstet Gynecol Scand. 69: 399-403.
88. Rudolph MI, Bardisa L, Cruz MA, Reinicke K (1992). Mast cell mediators evoke contractility and potentiate each other in mouse uterine horns. Gen Pharmacol. 23: 833-836.
89. Rudolph MI, Reinicke K, Cruz MA, Gonzalez C, Bardisa L (1993). Distribution of mast cells and the effect of their mediators on contractility in human myometrium. Br J Obstet Gynecol. 100: 1125-1130.
90. Rudolph MI, Cabanillas A, Gómez P, Garcia MA, Villán L (1997a). On the mechanism of action of ethodin in inducing myometrium contractions. Gen Pharmacol. 28: 381-385.
91. Rudolph MI, Garcia MA, Sepúlveda M, Brandan E, Reinicke K, Nicovani S, Villán L (1997b). Ethodin: Pharmacological evidence of the interaction between smooth muscle and mast cells in the myometrium. J Pharmacol Exper Ther. 282: 256-261.
92. Rudolph MI, Oviedo C, Martinez L, Reinicke K, Villar M, Villán L (1998). Oxytocin inhibits the uptake of serotonin into uterine mast cells. J Pharmacol Exper Ther. 287: 389-394.
93. Sautebin L, Lalenti A, Ignarro A, Rosa MD (1995). Modulation by nitric oxide of prostaglandin biosynthesis in the rat uteri. Br J Pharmacol. 114: 323-328.
94. Schmauder-Chock E, Chock SP (1989). Localization of cyclooxygenase and prostaglandin E2 in the secretory granule of the mast cell. J Histochem Cytochem. 37: 1319-1328.
95. Schmith A, Goepfert C, Feitsma K, Buddecke E (2002). Lovastatin-stimulated superinduction of E-selectin, ICAM-I and VCAM in TNFa activated human vascular endothelial cells. Atherosclerosis. 164: 57-64.
96. Schubert W, Cullberg G (1987). Second trimester abortion by rivanol with or without cervical dilatators. Acta Obstet Gynecol Scand. 66: 549-550.
97. Schwartz LB (1997). Understanding human parturition. Lancet. 350: 1792-1793.
98. Shum JKS, Melendez JA, Jeffrey JJ (2002). Serotonin-induced MMP-13 production is mediated via Phspholipase C, protein kinase C, and ERK1/2 in rat uterine smooth muscle cells. J Biol Chem. 277: 42830-42840.
99. Singh LK, Boucher W, Pang X, Letourneau R, Seretakis D, Green M, Theoharides TC (1999). Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of CRH receptors. J Pharmaol Exp Ther. 288: 1349-1356.
100. Slominski A, Wortsman J, Pisarchik A, Zbytek B, Linton EA, Mazurkiewicz JE, Wei ET (2001). Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J. 15: 1678-1693.
101. Soloff MS, Sweet P (1982). Oxytocin inhibition of (Ca-Mg)ATPase activity in rat myometrial plasma membranes. J Biol Chem. 257: 10687-10693.
102. Spangaard H, Knudsen UB, Uldberg N, Jerzioska M, Woolley DE, Danielsen CC (1997). Mast cells in cervical ripening- an immunohistochemical and biochemical study in rats. Eur J Obstet Gynecol Reprod Biol. 73: 91-97.
103. Stenton GR, Vliagoftis H, Befus D (1998). Role of intestinal mast cells in modulating gastrointestinal pathophysiology. Ann Allergy Asthma Immunol. 85: 1-15.
104. Tabb NT (1994). Immune control of myometrial contractility: Role of mast cells. In: Control of uterine contractility. RE Garfield, NT Tabb, Eds. CRC Press, Boca de Raton, FL. pp. 355-373.
105. Theoharides TC, Singh LK, Boucher W, Pang X, Letourneau R, Webster E, Chrousos GP (1998). Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory affects. Endocrinology. 139: 403-413.
106. Thompson AJ, Telfer JF, Young A, Campbell S, Stewart CJR, Cameron IT, Greer IA, Norman JE (1999). Leukocytes infiltrate the myometrium during human parturition: further evidence that labor is an inflammatory process. Hum Reprod. 14: 229-236.
107. Tkaczyk C, Frandji P, Botros HG, Poncet P, Lapeyre J, Peronet R, David B, Mecheri S (1996). Mouse bone marrow-derived mast cells and mast cell lines constitutively produce B cell growth and differentiation activities. J Immunol. 157: 1720-1728.
108. Umezaki H, Valenzuela GJ, Hess DL, Ducsay CA (1993). Fetectomy alters maternal endocrine and uterine activity rhythms in rhesus macaques during late gestation. Am J Obstet Gynecol. 169: 1435-1441.
109. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF (1991). Human dermal mast cells contain and relese tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule I. Proc Natl Acad Sci USA. 88: 4220-4224.
110. Weiss G (2000). Endocrinology of parturition. J Clin Endocrinol Metab. 85: 4221-4225.
111. Wershil BK, Galli SJ (1991). Gastrointestinal mast cells. New approaches for analyzing their function in vivo. Gastroenterol Clin NA. 20: 613-627.
112. Wilcox BD, Ridelek-Fitzgerard L, Jeffrey JJ (1992). Regulation of collagenase gene expression by serotonin and progesterone in rat uterine smooth muscle cells. J Biol Chem. 267: 20752-20757.
113. Yallampalli C, Izumi H, Byam-Smith M, Garfield R (1993). An L-arginine-nitric oxide-cyclic guanosine monophosphate system exists in the uterus and inhibits contractility during pregnancy. Am J Obstet Gynecol. 170: 175-185.
114. Zingg HH, Rozen F, Chu K, Larcher A, Arian A, Richard S, Lefebvre D (1995). Oxytocin and oxytocin receptor gene expression in the uterus. Recent Progr Hormone Res. 50: 255-273.